Distribution of edin in Staphylococcus aureus isolated from diabetic foot ulcers

Clinical Microbiology and Infection

Volumn 19, Issue 9, 2013, Pages 875-880

  Messad, N ^a   Landraud, L ^b,c   Canivet, B ^d   Lina, G ^e   Richard, J L ^f   Sotto, A ^a   Lavigne, J P ^a,g   Lemichez, E ^b  

^a INSERM   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d PASTEUR HOSPITAL   (France)

^e UNIVERSITÉ LYON 1   (France)

^f NÎMES UNIVERSITY HOSPITAL   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Colonization; Diabetic foot ulcer; EDIN; Oligonucleotide array; Severe infection; Staphylococcus aureus

Indexed keywords

BACTERIAL TOXIN; EPIDERMAL DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DIABETIC FOOT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN LOCALIZATION;

STAPHYLOCOCCUS AUREUS;

EID: 84882604390     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12084     Document Type: Article

References (26)

1. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 1998; 21: 2161-2177.
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
3. Lowy FD. How Staphylococcus aureus adapts to its host. N Engl J Med 2011; 364: 1987-1990.
4. Edwards AM, Potts JR, Josefsson E, Massey RC. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog 2010; 6: e1000964.
5. Edwards AM, Massey RC. How does Staphylococcus aureus escape the bloodstream? Trends Microbiol 2011; 19: 184-190.
6. Inoue S, Sugai M, Murooka Y et al. Molecular cloning and sequencing of the epidermal cell differentiation inhibitor gene from Staphylococcus aureus. Biochem Biophys Res Commun 1991; 174: 459-464.
7. Aktories K. Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 2011; 9: 487-498.
8. Jaffe AB, Hall A. RHO GTPases: Biochemistry and Biology. Annu Rev Cell Dev Biol 2005; 21: 247-269.
9. Nusrat A, Giry M, Turner JR et al. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci USA 1995; 92: 10629-10633.
10. Boyer L, Doye A, Rolando M et al. Induction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors. J Cell Biol 2006; 173: 809-819.
11. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 282: 1717-1721.
12. Lemichez E, Lecuit M, Nassif X, Bourdoulous S. Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat Rev Microbiol 2010; 8: 93-104.
13. Sotto A, Richard JL, Messad N et al. Distinguishing colonization from infection with Staphylococcus aureus in diabetic foot ulcers with miniaturized oligonucleotide arrays: a French multicenter study. Diabetes Care 2012; 35: 617-623.
14. Sotto A, Lina G, Richard JL et al. Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: a new paradigm. Diabetes Care 2008; 31: 2318-2324.
15. Lipsky BA, Berendt AR, Embil J, De Lalla F. Diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2004; 20: S56-S64.
16. Lipsky BA, Peters EJ, Berendt AR et al. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev 2012; 28: 234-235.
17. Soussy CJ and the Antibiogram committee of French Society of Microbiology. Antibiotic Susceptibility Testing. Available from http://www.sfm-microbiologie.org, French Society for Microbiology (last accessed July 2, 2012).
18. Monecke S, Slickers P, Ehricht R. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 2008; 53: 237-251.
19. Monecke S, Coombs G, Shore AC et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 2011; 6: e17936.
20. Franke GC, Bockenholt A, Sugai M, Rohde H, Aepfelbacher M. Epidemiology, variable genetic organization and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients. Microbiology 2010; 156: 860-872.
21. Sugai M, Hashimoto K, Kikuchi A et al. Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem 1992; 267: 2600-2604.
22. Yamaguchi T, Hayashi T, Takami H et al. Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. Infect Immun 2001; 69: 7760-7771.
23. Yamaguchi T, Nishifuji K, Sasaki M et al. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun 2002; 70: 5835-5845.
24. Munro P, Clement R, Lavigne JP, Pulcini C, Lemichez E, Landraud L. High prevalence of edin-C encoding RhoA-targeting toxin in clinical isolates of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2011; 30: 965-972.
25. Munro P, Benchetrit M, Nahori MA et al. Staphylococcus aureus EDIN toxin promotes formation of infection foci in a mouse model of bacteremia. Infect Immun 2010; 78: 3404-3411.
26. Richard JL, Lavigne JP, Sotto A. Diabetes and foot infection: more than double trouble. Diabetes Metab Res Rev 2012; 28: 46-53.